Skip to main content
FEMY
NASDAQ Industrial Applications And Services

Femasys Proxy Reveals Director Resignation, New Appointments, and Related Party Compensation Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.373
Mkt Cap
$22.055M
52W Low
$0.307
52W High
$1.22
52W Position info
21% above low
Off High info
69% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

FEMY sits 21% above its 52-week low of $0.307.

Summary

Femasys Inc. filed its definitive proxy statement for the upcoming annual meeting, revealing a recent director resignation, new executive appointments, and a notable related party compensation disclosure, all against the backdrop of the company's previously disclosed going concern risk.


Key Events · Corporate Governance and Compliance · FEMY

  • Annual Shareholder Meeting Scheduled

    Femasys Inc. will hold its 2026 Annual Meeting of Stockholders on June 24, 2026, to vote on director elections and auditor ratification.

  • Director Resignation and New Appointment

    Joshua Silverman resigned from the Board of Directors on March 17, 2026. Kenneth Eichenbaum, appointed in March 2026, is nominated for election as a Class II director.

  • Executive Officer Changes

    Daniel Currie retired as Chief Operating Officer effective December 15, 2025. John Canning was appointed Chief Operating Officer in March 2026, and Jeremy Sipos was appointed Chief Technology Officer in December 2025.

  • Related Party Compensation Disclosure

    The company disclosed that the CEO's daughter, Kayla Carlton, received $237,000 in total compensation and benefits in 2025, which is a significant amount relative to the company's market capitalization.


Analysis · FEMY · Industrial Applications And Services

This definitive proxy statement provides key updates on Femasys Inc.'s corporate governance ahead of its annual meeting. The resignation of director Joshua Silverman in March 2026, coupled with the company's previously disclosed "going concern" warning, could signal internal instability or a lack of confidence. Additionally, the disclosure of a significant related party transaction involving the CEO's daughter, with compensation exceeding $237,000, warrants investor attention given the company's financial challenges. While the election of directors and auditor ratification are routine, these specific details add a layer of scrutiny for investors monitoring the company's operational and financial health.

At the time of this filing, FEMY was trading at $0.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $22.1M. The 52-week trading range was $0.31 to $1.22. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Jun 24, 2026, 9:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.15
Real-time Price: $2.91 info
Change: -$1.24 (-30%) info
Market Cap: $8.908M info
FEMY
Jun 05, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.310
Real-time Price: $2.91 info
Change: Reverse Stock Split info
Market Cap: $8.908M info
FEMY
Jun 04, 2026, 9:03 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.3416
Real-time Price: $2.91 info
Change: Reverse Stock Split info
Market Cap: $8.908M info
FEMY
Jun 04, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3591
Real-time Price: $2.91 info
Change: Reverse Stock Split info
Market Cap: $8.908M info
FEMY
May 13, 2026, 4:48 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3814
Real-time Price: $2.91 info
Change: Reverse Stock Split info
Market Cap: $8.908M info